Cargando…
Ventricular Bigeminy after Subcutaneous Administration of Apomorphine in a Patient with Refractory Parkinson’s Disease: A Case Report
Apomorphine is a well established treatment for the management of sudden, unexpected and refractory levodopa-induced “off” states in fluctuating Parkinson’s disease either as bolus injections or as continuous infusions. Incidents of atrial fibrillation associated with the administration of the drug...
Autores principales: | Kaminioti, Anastasia N., Nikitas, Georgios T., Terlis, Apostolos K., Manolis, Athanasios G., Thomaides, Thomas, Panousopoulou, Aggeliki N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027651/ https://www.ncbi.nlm.nih.gov/pubmed/24868418 http://dx.doi.org/10.14802/jmd.13002 |
Ejemplares similares
-
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020) -
Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021) -
Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016) -
Cannabinoid hyperemesis syndrome presenting with ventricular bigeminy
por: Wong, Jeffrey, et al.
Publicado: (2023) -
Symptomatic Ventricular Bigeminy and Trigeminy Associated With COVID-19
por: Hu, Janie, et al.
Publicado: (2023)